prosigna at a glance : clinical implications of the breast cancer intrinsic subtypes
Published 1 year ago • 211 plays • Length 3:59Download video MP4
Download video MP3
Similar videos
-
3:50
components of prognostic biomarkers
-
22:13
prosigna: development, validation, and main studies
-
1:04:04
the history and evolution of pam50 & prosigna@
-
3:47
prosigna information video for breast cancer patients
-
29:36
comparison of pam50 intrinsic subtype profiles in matched primary and metastatic breast cancer
-
8:13
contribution of germline predisposition gene mutations to clinical subtypes of breast cancer
-
59:46
cgc webinar: accelerating pediatric cancer research: harnessing the power of the openpedcan project
-
3:52
prosigna information video for healthcare providers
-
46:35
what are the advantages of using a second-generation genomic test?
-
1:32:10
intrinsic molecular subtypes and treatment decisions
-
47:22
dr. aju mathew, assistant professor of medicine talking on breast cancer at our foster city lab
-
1:05
the genomic characterization of primary and metastatic her2-low breast cancers
-
26:04
2022 ku post san antonio review | integration of biomarkers to inform treatment decisions
-
20:07
decoding breast cancer with quantitative radiomics & radiogenomics - maryellen giger
-
4:55
advancing our understanding of basal-like, luminal a, and luminal b breast cancers
-
4:30
nanostring technology: identifying subtypes
-
5:28
mutational landscapes in pregnant and non-pregnant breast cancer
-
55:42
evolution of surgical care in breast cancer